PHOSPHORYLATION OF HUMAN I-KAPPA-B-ALPHA ON SERINE-32 AND SERINE-36 CONTROLS I-KAPPA-B-ALPHA PROTEOLYSIS AND NF-KAPPA-B ACTIVATION IN RESPONSE TO DIVERSE STIMULI
Ebm. Traenckner et al., PHOSPHORYLATION OF HUMAN I-KAPPA-B-ALPHA ON SERINE-32 AND SERINE-36 CONTROLS I-KAPPA-B-ALPHA PROTEOLYSIS AND NF-KAPPA-B ACTIVATION IN RESPONSE TO DIVERSE STIMULI, EMBO journal, 14(12), 1995, pp. 2876-2883
Post-translational activation of the higher eukaryotic transcription f
actor NF-kappa B requires both phosphorylation and proteolytic degrada
tion of the inhibitory subunit I kappa B-alpha, Inhibition of proteaso
me activity can stabilize an inducibly phosphorylated form of I kappa
B-alpha in intact cells, suggesting that phosphorylation targets the p
rotein for degradation, In this study, we have identified serines 32 a
nd 36 in human I kappa B-alpha as essential for the control of I kappa
B-alpha stability and the activation of NF-kappa B in HeLa cells, A p
oint mutant substituting serines 32 and 36 by alanine residues was no
longer phosphorylated in response to okadaic acid (OA) stimulation. Th
is and various other Ser32 and Ser36 mutants behaved as potent dominan
t negative I kappa B proteins attenuating kappa B-dependent transactiv
ation in response to OA, phorbol 12-myristate 13-acetate (PMA) and tum
or necrosis factor-alpha (TNF), While both endogenous and transiently
expressed wild-type I kappa B-alpha were proteolytically degraded in r
esponse to PMA and TNF stimulation of cells, the S32/36A mutant of I k
appa B-alpha remained largely intact under these conditions, Our data
suggest that such diverse stimuli as OA, TNF and PMA use the same kina
se system to phosphorylate and thereby destabilize I kappa B-alpha, le
ading to NF-kappa B activation.